6th Month Update
The persistent ringing in my left ear gradually disappeared from the first month, and the constipation situation also improved gradually. However, although there has been improvement in the condition of pulmonary edema, it has not completely healed. My primary doctor asked if I wanted to continue with the cancer drug, Icotinib. However, the monthly burden of over forty thousand in hospital fees makes it challenging, especially for a prolonged battle. Consequently, I sought a second opinion. The doctor, reviewing the “medical summary” from my original hospital, found that I might also have the EGFR 858R gene mutation. He informed me that Entrectinib may not be as effective for me, and it might be the support from Icotinib that has been holding back the progression, as evidenced by the significant improvement in my July and August CT scan results.
The doctor also mentioned that the side effect of Icotinib is hypertension, and having high blood pressure indicates a better treatment response. Ironically, I have lower blood pressure 😅. Moreover, the doctor explained that the CEA index varies with the amount of pulmonary edema; right after draining the fluid, the CEA index tends to be lower. Concerning my lung water status, the doctor promptly recommended another X-ray, with a follow-up in the outpatient clinic after five days to determine the growth rate of the edema. Such an experimental spirit from the doctor!
On October 24, the blood test revealed my CEA had dropped to 72, with a slow monthly decrease of around 15. CA19-9 was within the normal range at 9, but CA125 was 170. This elevation was attributed to the timing of my menstrual cycle during the blood draw, but further clarification of gynecological issues is necessary. In this month, I decided to stop taking Avastin, unknowingly setting the stage for the unfortunate events in the following months.